Medscape

Redefining Care: Nonsurgical Pathways in Early Breast Cancer

There is a promising shift toward nonsurgical treatment strategies in early breast cancer, as clinicians aim to reduce harm ...
Medical Xpress

Study provides insights into early breast cancer development in individuals with BRCA2 mutations

A pioneering study led by Professor Ashok Venkitaraman from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore and Dr. Mona Shehata from the University ...
Nature

Use of ctDNA in early breast cancer: analytical validity and clinical potential

Circulating free tumor DNA (ctDNA) analysis is gaining popularity in precision oncology, particularly in metastatic breast cancer, as it provides non-invasive, real-time tumor information to ...
Nature

Dynamic changes in B cell subpopulations in response to triple-negative breast cancer development

Despite presenting a worse prognosis and being associated with highly aggressive tumors, triple-negative breast cancer (TNBC) is characterized by the higher frequency of tumor-infiltrating lymphocytes ...
Business Wire

Genentech’s Giredestrant Becomes the First Oral SERD to Show Superior Invasive Disease-Free Survival in Early Breast Cancer

-lidERA is the second positive Phase III readout for giredestrant following evERA presented at ESMO 2025- SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ...